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Abstract 
Objective: To investigate the antifungal potential of A. colubrina, and its phytochemical 
characteristics, thermal profile and toxicity. Material and Methods: To assess potential 
antifungal activity, the technique of microdilution was used with the determination of 
the Minimum Inhibitory Concentration and Minimum Fungicidal Concentration, using 
standard species of Candida and recent clinical isolates of Candida albicans. Analyses of 
action of the extract were performed on the wall and cell morphology of C. albicans, of 
the interactive effect between the plant extract and nystatin on C. albicans through the 
checkerboard method, and of growth kinetics. The phytochemical screening was 
determined by spectrophotometry. The thermal profile was traced with the 
determination of thermogravimetric curves (TG) and differential scanning calorimetry 
(DSC). The toxicity was evaluated by the method of hemolysis. Results: The extract of 
A. colubrina showed a fungistatic potential against all bacteria tested and it acted by 
modifying the cellular morphology of C. albicans. There was a synergism between 
nystatin and the plant extract (FIC=0.375), and 53.18% of total polyphenols were 
determined. The TG curve showed the occurrence of three steps of thermal 
decomposition. None of the tested concentrations became the effective cytotoxic 
concentration. Conclusion: Further studies should be conducted to understand the 
efficacy and the mechanisms of action involved in the antifungal activity of the plant 
extract of A. colubrina in order to produce a new drug for the treatment of oral 
candidiasis. 
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Introduction 
Oral candidiasis is an opportunistic infection that has a high occurrence rate and that is 
frequently associated with Candida albicans [1]. The predisposing factors for its development can be 
classified into local factors such as use of prosthesis, reduced salivary flow and sugar-rich diet, and 
systemic factors such as advanced age, endocrine disorders, immunosuppression, use of broad-
spectrum antibiotics and nutritional deficiencies [2]. 
Among the most appropriate drugs used for the treatment of oral candidiasis, miconazole, 
from the group of azoles, and nystatin, from the group of polyenics, stand out [3]. Despite its 
efficacy, miconazole can trigger undesired drug interactions, reducing drug absorption and 
increasing the risk of adverse effects through inhibition of human cytochrome P450 [4,5]. Nystatin, 
because it binds directly to ergosterol and interacts with a component of the human membrane 
(cholesterol), may lead to side effects [6,7]. Thus, there is a demand for new antifungals with 
different structural classes that can act selectively on new cellular targets with fewer side effects [8]. 
In this perspective, the antifungal activity of medicinal plants, aiming to develop new drugs, has been 
investigated. 
Among plants used by the population for medicinal purposes is the Anadenanthera colubrina 
(Vell.) Brenan, used to treat diarrhea, cough, bronchitis, the flu, inflammation and tissue damage, 
allergy, rash, constipation, gastritis, among other uses [9-11]. An analgesic action of parts of this 
plant was identified. It is a result of its antinoceptive effects mediated by central and peripheral 
mechanisms [12] and with a potential healing and tissue repair action [13]. Regarding antimicrobial 
activity, activity against P. aeruginosa [14], Staphylococcus aureus [15] and Candida albicans [16] was 
observed. This study aims to investigate the activity antifungal, phytochemical and thermic profil of 
the hydroalcoholic extract of the bark of Anadenanthera colubrina (Vell.) Brenan. 
 
Material and Methods 
Plant Extract Collection 
Barks from Anadenanthera colubrina (Vell.) Brenan were used. They were collected in the 
region of the Brazilian semi-arid (7º22'25" S, 35°59'32" W) with the guidance of a botanist. The 
testimony specimen is deposited in the collection of the Herbarium Manuel de Arruda Câmara 
(ACAM) of the State University of Paraíba, Campina Grande, Paraiba, under registration nº 
667/ACAM. The material was dehydrated in an air circulating oven at 40°C, subsequently ground 
and then immersed in ethyl alcohol 80% (10g/25mL) for 48 hours at room temperature. The 
resulting mixture was filtered and the filtration residues were immersed again twice in the solvent. 
The final three liquid phases were concentrated on a rotary evaporator in vacuum at 39°C, 
subsequently lyophilized and kept under refrigeration. 
 
Antimicrobial Activity 
Microorganisms 
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The microorganisms used were Candida albicans (ATCC 18804), Candida krusei (ATCC 
34135), Candida glabrata (ATCC 15545), Candida guillermondii (ATCC 6260), Candida parapsilosis 
(ATCC 22019), Candida tropicalis (ATCC 13803), all provided by the Reference Materials Laboratory 
of National Institute for Health Quality Control (Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 
Brazil), and fresh isolates of Candida albicans (LM 11, LM 520 LM 70, LM 410) were provided by the 
Mycology Laboratory of the Federal University of Paraíba. 
 
Determination of Minimum Inhibitory Concentration (MIC) 
Minimum Inhibitory Concentration (MIC) was determined by broth microdilution technique 
using 96-well plates (Alamar Tecno Científica Ltda., Diadema, SP, Brazil) in accordance with the 
provisions of the document M27A2 [17]. The inoculum with a 24-hour growth was standardized in 
a spectrophotometer, corresponding to 2.5 x 103 CFU/mL. To each well of the microtiter plate 100 
µL of broth culture medium Sabouraud dextrose, 100 µL of plant extract, whose concentration 
ranged from 15.62 to 2,000 μg/mL, and 100 µL of the inoculum were placed (final concentration: 5 x 
106 UFC/mL). The viability control of the tested yeast strain and the sensitivity control to nystatin 
of the strain were made. The plates were incubated for 24 hours at 37°C. After the incubation period, 
10 μL of the aqueous solution of resazurin 0.01% were added to each well to perform a MIC reading. 
Viable microorganisms were reduced from a blue color to a pink color. The experiment was 
performed in triplicate on three different occasions. 
 
Determination of the Minimum Fungicidal Concentration (MFC) 
After determining the MIC, the concentration corresponding to the inhibitory and to higher 
concentrations, as well as the controls, were subcultured on Sabouraud dextrose agar plates. After 24 
hours of incubation at 37°C, MFCs' readings were made, being the MFC the lowest extract 
concentration in which a visible growth of the subculture was prevented. 
 
Action of the Extract on the Cell Wall of Candida albicans 
The action of the extract on the cell wall was analyzed by the microdilution in broth 
technique, with MIC determination, in the presence of sorbitol (0.8 M). Microtiter plates containing 
96 wells, with the bottom in a "U" shape, were used (Alamar Tecno Científica Ltda., Diadema, SP, 
Brazil). In each well of the plate, 100 µL of broth culture medium Sabouraud Dextrose, previously 
added to sorbitol with molecular weight of 132,17g (Vetec Fine Chemicals Ltda., Rio de Janeiro, RJ, 
Brazil), and 100 mL of the extract in concentrations from 32 to 0.25 mg/mL were added. Then, 10 μL of the microbial inoculum were added at a concentration of 2.5 x 103 CFU/mL in each well. The 
microplates were seeded and incubated at 37°C for 48 hours, then added to an aqueous resazurin 
0.01% solution to perform the MIC reading. The experiment was performed in triplicate. 
 
Cell Morphology Analysis of Candida albicans 
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The cellular morphology of C. albicans treated with the plant extract was analyzed by 
scanning electron microscopy (SEM). Aliquots of fungal strains treated with the plant extract and 
nystatin, and antifungal free strains in culture medium, were centrifuged at 3,500 rpm for 15 minutes 
to perform deposition of organic material. The supernatant was removed and the samples were fixed 
with a solution of 2.5% glutaraldehyde and 0.1 M cacodylate buffer. There was a new centrifugation 
and a subsequent wash with Caco Buffer 0.1M. After removing the buffer, the fungal material was 
inserted into a glass coverslip to be processed. The processing consisted of three washes with B. 
Caco 0.1M for 10 minutes, post-fixation at a 1:1 proportion + Osmium 2% + B. Caco 0.1M for 30 
minutes to enable a greater material contrast upon reading, two washes with B. Caco 0.1M for 10 
minutes and two washes with distilled water for 10 minutes. Dehydration was also performed with a 
wash in acetone at concentrations of 30%, 50%, 70%, 90% and 100%. The material was dried in a 
Critical Point (CPD 030 BAL-TEC) for 2 hours, and then the assembly in stubbs was made (carbon 
tape and silver ink). The stubbs act as electron conductors. Finally, the gold plating was performed 
for 30 minutes in a sputtering system (Leica EM SCD 500) and then it was analyzed by scanning 
electron microscope (Quanta 200 FEG, Fei Company, Oregon, USA). 
 
Analysis of the Interactive Effect 
Checkerboard Method 
The combined effect of the two substances (nystatin and plant extract of A. colubrina) was 
determined from the microdilution-checkerboard method for derivation of the Fractional Inhibitory 
Concentration index (FIC index). The microbial inoculum was standardized in a spectrophotometer 
to obtain a 2.5 x 103 CFU/mL concentration. The extract and the nystatin were tested considering 
the MIC. Initially, 100μL of the Sabouraud dextrose agar broth culture medium was added to 
sterilized microplate wells containing 96 wells with a "U" shape (Alamar Tecno Científica Ltda., 
Diadema, SP, Brazil) Then, 50μL of each substance in concentrations MIC/8, MIC/4, MIC/2, MIC, 
MICx2, MICx4 and MICx8 were added to the microplate, and finally the inoculum was added. The 
extract was placed on horizontal lines and the nystatin on vertical lines. The microplates were 
incubated at 37°C for 48 hours and fungal growth was evidenced by the use of an aqueous 0.01% 
resazurin solution. The experiment was performed in triplicate. 
The FIC index was calculated by the sum of the FICA + FICB, where A represents the plant 
extract and B the nystatin. The FICA is calculated by the MICA combined (extract+nystatin)/MICA 
alone, while the FICB = MICB combined (extract+nystatin)/MICB alone. This index was interpreted 
as follows: synergism (<0.5), additivity (0.5-1.0), indifference (>1 and <4) or antagonism (>4) [18].  
 
Growth Kinetics 
The study of the interference of the plant extract, associated or not to nystatin, on the 
growth of C. albicans was conducted through the viable cell count method. Initially, 0.5 mL of yeast 
suspension was inoculated to 4.5 mL of Sabouraud dextrose broth containing different 
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concentrations of the extract (MIC/8; MIC/4, MIC), nystatin (MIC/8; MIC/4, MIC) and two 
associations of substances (MIC/8 of extract + MIC/4 of nystatin and MIC/8 of nystatin + MIC/4 
of extract). At 0 min and 30 min intervals, 1, 2, 3, 4, 5, 6, 12 and 24 hours after incubation, an aliquot 
of 10μL of this inoculum was evenly inoculated on Petri plates containing Sabouraud dextrose agar 
culture medium. In addition, the control experiment was carried out with free antifungal growth. 
The inoculated plates were incubated at 35°C for 48 hours. After the incubation period, the counting 
of the number of viable cells was made. It was expressed as CFU/mL and presented in the form of a 
microbial kill curve. Data were analyzed and processed using SPSS software version 20.0. The 
Friedman and Kruskal-Wallis tests were made with a 5% significance level. 
 
Phytochemistry Prospecting 
To determine the total polyphenol content, the colorimetric method was used. It uses the 
Folin-Ciocalteu reagent [19]. 1 mL of the aqueous extract solution was added to 1 mL of the Folin-
Ciocalteu 1N reagent and, after a 2-minute rest, 2 mL of an aqueous solution of Na2CO3 at 20% (p/v) 
was added, then allowing it to rest for another 10 minutes. Then, the absorbance reading at 757nm 
was made in a spectrophotometer (Shimadzu® UV mini - 1240), against a blank composed of distilled 
water, Folin-Ciocalteu reagent and 20% of a solution of Na2CO3. The calibration curve was obtained 
from gallic acid solutions at concentrations of 1, 3, 6, 9, 12, 15, 20, 25, 30, 35, and 40 mg/mL. The 
concentration of polyphenols was measured in equivalent milligrams of gallic acid.  
The determination of the total flavonoid content was performed by adding 5 mL of each 
extract solution (in methanol) to the same volume of a solution (in methanol) of AlCl2 at 2% (p/v) 
[20]. The mixture rested 10 minutes before the absorbance reading at 415 nm against a blank 
consisting of an AlCl3 solution was made. For this determination, a calibration curve obtained from 
quercetin solutions at concentrations of 2, 4, 6, 8, 10, 13, 16, 19, 22, 26, 28 and 30 μg/ml was made. 
The concentration of flavonoids was expressed in equivalent milligrams of quercetin.  
The content of condensed tannins was quantified by adding 0.5 mL of the sample plant 
extract to 3 mL of a vanillin solution (4% p/v in methanol). Then, 1.5 mL of concentrated HCl (37%) 
was added [21]. The reaction occurred in test tubes soaked in water at about 22°C. The reading was 
taken at 500nm against a blank consisting of the vanillin solution, HCl and a solution of ethanol 50% 
(v/v) in water. The calibration curve for this assay was made using catechin solutions at 
concentrations of 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 μg/mL. The concentration of tannins was 
expressed as equivalent milligrams of catechin. All analyzes were performed in triplicate. 
 
Thermal Profile 
Thermogravimetric curves (TG) were obtained with a simultaneous analyzer Model SDT 
Q600 (TA Instruments) using alumina crucibles containing samples with 8±0.1 mg, in a nitrogen 
atmosphere, under a flow of 50 mL.min-1. The experiments were conducted between temperature 
ranges from 25 to 900°C at a heating rate of 10°C min-1. For the calibration of the equipment, a 
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standard calcium oxalate monohydrate was used. DSC curves were obtained from a calorimeter 
Model DSC Q20 (TA Instruments) using alumina crucibles containing samples with 2±0.1 mg, in a 
nitrogen atmosphere, under a flow of 50 mL.min-1. The experiments were conducted between 
temperature ranges from 25 to 400°C at a heating rate of 10°C min-1. For the calibration of the 
equipment, an Indium standard (m.p. = 156.6°C) was used. 
 
Toxicity 
The toxicity of A. colubrina extract was analyzed by the hemolysis method. A red 4% blood 
cell suspension was prepared in a 0.9% saline solution. Then, 1 mL of this suspension was distributed 
in test tubes and homogenized with 1 mL of the diluted extract in different concentrations in order 
to obtain 0.25, 0.5, 1, 2, 4, 8, 16 and 32 mg/mL. After 1 hour, the samples were centrifuged at 3,000 
rpm for 10 minutes and the reading was visually performed, taking into consideration the amount of 
erythrocytes lysed. The hemolysis visualization was classified as - (0% hemolysis) + (25% hemolysis), 
++ (50% hemolysis), +++ (75% hemolysis), and ++++ (100% hemolysis) [22]. This reading was 
made in a spectrophotometer with a 540nm wavelength (Shimadzu® UV mini - 1240), using as a 
blank a 5% saline solution to confirm the results of the visual reading. Two negative controls were 
used, one being the suspension of 4% red blood cells and the other the diluted plant extract. As a 
positive control, a Turk Liquid hemolizing solution was used. 
 
Results 
The extract of A. colubrina inhibited the growth of all strains of tested Candida (Table 1) and 
produced a slight change in the morphology of C. albicans ATCC 18804 (Figure 1). The MIC of the 
extract of this species increased from 1 mg/mL to 8 mg/mL in the presence of sorbitol. 
 
Table 1. Determination of Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal 
Concentration (MFC) of the hydroalcoholic extract of the bark of Anadenanthera colubrina  (Vell.) 
Brenan and of nystatin (Sigma-Aldrich®) against Candida  species. 
 Anadenanthera colubrina (Vell.) Brenan 
mg/ml 
Nystatin 
mg/ml 
 (MIC) (MFC) (MIC) (MFC) 
C. albicans (ATCC 18804) 1 >2 0.006 0.006 
C. glabrata (ATCC 15545) 0,5 >2 0.006 0.006 
C. krusei (ATCC 34135) 1 >2 0.006 0.03 
C. guillermond (ATCC 6260) 1 >2 0.006 0.006 
C. tropicalis (ATCC 13803) 1 >2 0.006 0.01 
C.albicans LM11 0,5 0.5 0.006 0.006 
C.albicans LM70 0.25 0.25 0.006 0.006 
C. albicans LM 410 0.5 0.5 0.006 0.006 
 
The interactive effect of the extract of A. colubrina and nystatin showed a synergistic activity, 
with a FIC equal to 0.375 (Table 2) and a reduction of the number of CFU/mL (p <0.05) in the first 
6 hours (Figures 2, 3 and 4). 
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Figure 1. Photomicrography by Scanning Electron Microscopy (SEM) of strains of treated Candida 
albicans  (ATCC 18804). A: nystatin (100,000 IU suspension); B: plant extract (1 mg/mL); and C: 
untreated, after 24 hours of incubation at 37°C. 
 
Table 2. Minimum Inhibitory Concentration (MIC) (mg/mL) of plant extract and nystatin combined, 
and Fractional Inhibitory Concentration Index (FIC index) against C. albicans (ATCC 18804). 
Product MIC (combination) 
mg/Ml 
Vegetal Extract  0.25 0.125 
Nystatin 0.00075 0.0015 
FIC 0.375 0.375 
 
 
Figure 2. Kinetics of C. albicans  growth (ATCC 18804) under the activity of the test products in MIC. 
 
 
Figure 3. Kinetics of C. albicans  (ATCC 18804) growth under the activity of the test products in 
MIC/4.  
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Figure 4. Kinetics of C. albicans  (ATCC 18804) growth under the activity of the test products in 
MIC/8. 
 
The TG curve of the extract of A. colubrina showed the occurrence of three stages of thermal 
decomposition and the DSC curves of the extract showed that the thermal processes occurred in 
temperature ranges from 52.37 to 195,52ºC (Figure 5). 
 
 
Figure 5. TG and DSC curves. 10°C min-1 heating rate. Temperature ranges from 25 to 900°C for TG, 
and from 25 to 400°C for DSC. 
 
 
In the hemolysis assay, the extract of A. colubrina showed a toxicity equivalent to 25% when 
compared to the positive control (Table 3). 
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Table 3.Visual reading of hemolysis of red blood cell suspensions tested with a lyophilized extract of 
Anandenanthera colubrina  Vell. Brenan. Reference: - (0% hemolysis) + (25% hemolysis, or below 25%), 
++ (50% hemolysis), +++ (75% hemolysis). 
Concentrations (mg/mL) Intensity Hemolysis 
32 + 
16 + 
8 + 
4 +  
2 +  
1 +  
0.5 +  
0.25 +  
Turk Liquid (Positive control) ++++ 
 
Discussion 
The hydroalcoholic extract of the bark of A. colubrina has an antifungal activity for different 
species of Candida, whose potential ranged from moderate to strong [23]. It is worth noting that 
other authors consider different parameters to assess the antimicrobial potential of medicinal plants, 
which is considered moderate or strong when the MIC is less than 500 mg/mL or 100 mg/mL, 
respectively [24]. These data are relevant especially when discussing sustainability and production 
of new pharmaceutical compounds. The extract of A. colubrina presented a fungistatic profile and was 
not fungicidal against species of Candida, which deserves attention when considering the balance and 
maintenance of oral microbiota, where the substance controls the growth of the microorganism 
without removing it completely from the surface where it commonly resides [25]. 
It is possible that the inhibition of growth of Candida species produced by the extract of A. 
colubrina has occurred due to its action on the cell wall, since its MIC increased in the presence of an 
osmotic shield, sorbitol. Slight alterations in the cell wall were observed in photomicrographs by 
scanning electron microscopy, especially represented by the loss of the typical rough aspect of the 
cell without treatment [16]. The action of the extract on the cell wall has a positive clinical 
significance, for it is a structure that mammalian cells do not have [7,26] which favors selectivity 
and therefore more security to the host. Although the results suggest the A. colubrina as a new source 
for the development of anti-fungal drugs with greater specificity, there is a great need for more 
research on its mechanism of action. 
Interaction tests of the extract of A. colubrina and nystatin indicated a synergistic effect, 
probably by acting simultaneously on different cellular targets. Nystatin acts on the membrane of the 
fungal cell [4,5] and A. colubrina extract acts possibly on the cell wall. Different mechanisms may be 
involved in synergistic activity between two agents. Some authors [27,28] described four of them: 
(1) inhibition of different stages in intracellular fungal biochemical pathways, essential to cell 
survival; (2) increased penetration of the antifungal agent provided by the action of another 
antifungal on fungal cell membrane; (3) inhibition of carrier proteinases; and (4) inhibition of 
different cellular targets simultaneously. 
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One of the simplest and most known protocols for determination of antimicrobial interaction 
is the checkerboard test, which provides a two-dimensional array of different concentrations of 
analyzed substances. This test allows the calculation of the Fractional Inhibitory Concentration 
Index (FIC index) [18]. The checkerboard test and the microbial kill curve are indicated for this 
evaluation in vitro [29]. The synergistic effect between A. colubrina extract and nystatin, even at low 
concentrations, was maintained over time with a reduction in the number of CFU/mL in relation to 
the control.  
The synergism between antifungal agents may increase the fungal clearance rate, shorten the 
duration of the therapy, prevent the emergence of drug resistance, broaden the spectrum of activity, 
and diminish the toxicity associated with the drug, allowing the use of lower doses of antifungal 
agents [30]. In this study, it was observed that the contact time of the substances with cells 
positively favored such reduction in the first 6 hours. The time factor is important in the prospecting 
of antifungals, for the prolonged use of antifungal agents and longer dosing regimens appear to 
contribute to the development of microbial resistance [31]. 
In the phytochemical prospecting, total polyphenols, tannins and flavonoids were identified. 
Their results are in agreement with the findings of other authors [32,33]. The high content of 
phenolic compounds found in the A. colubrina extract may be responsible for its antifungal potential. 
These compounds are capable of causing metabolic instability in C. albicans and they destroy the 
enzymatic activity of proteasomes, thereby contributing to a reduction in the growth rate of 
microorganisms, as well as biofilm formation and maturation [34]. The tannins are part of the group 
of phenolic compounds and have an antimicrobial activity due to the ability to precipitate proteins 
[35], leading to inactivation of adhesins, enzymes or the transport of proteins in the cell envelope, 
interfering with solute transportation or decreasing the availability of metal ions essential to the 
metabolism of microorganisms [36,37]. To a lesser extent, flavonoids have been identified, which 
also compose the group of phenolic compounds [38], and they may also be associated with the 
antifungal action of A. colubrina extract [38-40]. 
In thermogravimetric analysis, the first step of TG occurred at temperature ranges from 
39.17 to 141,26ºC, representing a mass loss of the sample of approximately 5.97%. This step was 
attributed to water loss and certain volatile products of the sample. This moisture content is in 
accordance with the criteria of the Brazilian Pharmacopoeia, which establishes for the control of 
plant material a limit of 14% as the maximum acceptable amount of moisture. The TG is an effective 
technique to determine the moisture content of the plant and, with these results, it is possible to 
establish physical parameters for an efficient drying and proper preservation of the material [41]. 
The second stage occurred within a temperature range from 141,26 to 229,17ºC, having a mass loss 
of 9.13%, corresponding to the first step of extract decomposition. The most significant mass loss of 
the extract was observed between the temperatures ranging from 229,17ºC and 657,39ºC, with loss 
of 37.44%. This event is probably related to the metabolites present in the plant, already identified as 
tannins and flavonoids. 
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In the DSC curve, an endothermic peak was observed at 69,96ºC, which may be related to the 
vaporization of the sample, with loss of water and volatile constituents. Decomposition processes 
start over 195,52ºC, which are possibly related to the initial decomposition of secondary metabolites 
present in the sample as flavonoids, tannins and other [41]. This high temperature for the beginning 
of compounds decomposition present in the plant suggests a good stability of the plant extract. The 
data obtained by thermal analysis are directly related to the final quality of a pharmaceutical product, 
either as to the therapeutic efficacy of the product or as to its stability throughout the period of 
validity. TGs are used to measure mass variation according to temperature in a controlled 
atmosphere under a heating program. The DSC is used to measure the heat flow difference between a 
substance and a reference material in function of a heating or cooling program. However, some 
difficulties are encountered in obtaining reproducible peaks of plant extracts in DSC curves.  This is 
because these extracts are a mixture of substances that interact in the vegetable matrix. In addition, 
the degradation products are often formed in different concentrations due to various factors such as 
the shape and imperfections of the particles, loss of gaseous products and the heating rate the sample. 
In addition, impurities present in plant extracts have a direct effect on the width of peaks obtained in 
the endothermic process [41,42].  
None of the tested concentrations became an effective 50% cytotoxic concentration (EC50), 
i.e., able to hemolyze 50% of a 4% suspension of erythrocytes in the hemolysis assay [43]. Thus, it 
was possible to determine the Selectivity Index (SI) of the plant extract, obtained by a IC50/MIC 
ratio greater than 32. The higher the value of SI, the more active it is against the microorganism and 
less toxic to the host [44]. The results indicate that A. colubrina can be considered a promising 
source for the development of new drugs. However, other studies in vitro should be conducted to 
assess biocompatibility and the mechanism of action of the A. colubrina extract, mimicking the 
biological conditions of the oral mucosa, as well as in vivo tests to prove its effectiveness aiming to 
produce a new drug for the treatment of oral candidiasis. 
Given the limitations of this study, oral cavity condition differs from in vitro status, further 
studies in vitro and in vivo should be conducted to understand the efficacy and the mechanisms of 
action involved in the antifungal activity of plant extract of A. colubrina in order to produce a new 
drug for the treatment of oral candidiasis. 
 
Conclusion 
The hydroalcoholic extract from the bark of Anadenanthera colubrina (Vell.) Brenan showed a 
fungistatic activity against Candida species and a synergistic interaction when combined with 
nystatin. It exhibited a high concentration of total polyphenols, a good thermal stability and an 
absence of toxicity to red blood cells.  
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